Abraxis BioScience Cash Flow Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | (0.6) | 4.5 | 18.4 | 32.2 | (40.3) |
| Net Investing Cash Flow | (6.3) | (7.6) | (24.4) | (11.0) | (42.4) |
| Net Financing Cash Flow | 0.0 | 707.2 | 0.1 | (12.8) | 72.6 |
| Net Change in Cash | (6.9) | 704.3 | (4.5) | 8.8 | (9.6) |
| Depreciation & Amortization | 13.1 | 12.6 | 26.2 | 24.8 | 24.1 |
| Capital Expenditures | (1.9) | (5.0) | (24.3) | (10.0) | (42.0) |
| Cash Dividends Paid | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
